Medexus Pharmaceuticals Inc. (MDP.TO) TSX

Currency In CAD

AD

Valuation

Market Cap62.49M
Enterprise Value75.69M
P/E Ratio-222.86
PEG Ratio2.06
Price/Sales Ratio0.93
Price/Book Ratio1.79
Enterprise/Revenue1.04
Enterprise/EBITDA6.53

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0
Operating Margin0.03
AD

Management Effectiveness

Return On Assets-0
Return On Equity-0.01

Income Statement

Revenue108.33M
Revenue/Share3.07
Gross Profit56.58M
EBITDA16.81M
Net Income2.25M
Diluted EPS0.08

Balance Sheet

Total Cash14.98M
Total Cash/Share0.46
Total Debt25.35M
Total Debt/Equity0.49
Current Ratio1.12
Book Value Per Share1.61

Price History

52-Week Change19.71
52-Week High4.25
52-Week Low2.47
Moving Average 50 Days3.98
Moving Average 200 Days3.16

Statistics

Average Volume51,673
Shares Outstanding32.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:15
Last Split DateDecember 19, 2018
AD